1,2,3,4,6,7,8-heptachlorodibenzodioxin has been researched along with Glomerulonephritis, Membranoproliferative in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, F; Imaizumi, C; Kaga, H; Komatsuda, A; Nanjo, H; Nara, M; Saito, A; Saito, M; Sawamura, M; Takahashi, N; Wakui, H | 1 |
1 other study(ies) available for 1,2,3,4,6,7,8-heptachlorodibenzodioxin and Glomerulonephritis, Membranoproliferative
| Article | Year |
|---|---|
Long-term prognosis of monoclonal immunoglobulin-associated glomerular diseases with non-organized deposits: A report of 38 cases from a Japanese single center.
Topics: Bortezomib; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Humans; Japan; Kidney Diseases; Multiple Myeloma; Polychlorinated Dibenzodioxins; Prognosis; Steroids | 2022 |